With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.34946-82-2,Copper(II) trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
To a solution of 2.00 g (4.82 mmol) of the above ieri-butyl ester in dimethylsulfoxide (15 mL) is added 1.10 mL (10.1 mmol) of dimethylethylenediamine followed by 0.983 g (9.64 mmol) of sodium methanesulfinate, and 1.74 g (4.82 mmol) of copper (II) triflate. The mixture is heated at 130 C under argon for 2 hours. The mixture is cooled to room temperature and diluted with water causing a solid to precipitate from solution. The formed solid is collected by filtration, washed with water, and dried on the filter pad. The residue is purified by flash silica gel chromatography to give 1.03 g (52.0%) of (5′- methanesulfonyl-3′-nitro-3,4,5,6-tetrahydro-2H-[l,2′]bipyridinyl-4-ylmethyl)-carbamic acid ie/ -butyl ester as a brown resin.
As the paragraph descriping shows that 34946-82-2 is playing an increasingly important role.
Reference£º
Patent; BOEHRINGER INGELHEIM INTERNATIONAL GMBH; GINN, John David; SORCEK, Ronald John; TURNER, Michael Robert; WU, Di; WU, Frank; WO2011/84985; (2011); A1;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”